These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12221545)

  • 61. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.
    Li TS; Tubiana R; Fillet AM; Autran B; Katlama C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):514-5. PubMed ID: 10225236
    [No Abstract]   [Full Text] [Related]  

  • 62. Retrospective study of CMV retinitis in patients with AIDS.
    Pauriah M; Ong EL
    Clin Microbiol Infect; 2000 Jan; 6(1):14-8. PubMed ID: 11168031
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resolution of giant Molluscum contagiosum with antiretroviral therapy.
    Sen S; Bhaumik P
    Indian J Dermatol Venereol Leprol; 2008; 74(3):267-8. PubMed ID: 18583804
    [No Abstract]   [Full Text] [Related]  

  • 64. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined treatment with zidovudine, lamivudine, nelfinavir and ganciclovir in an infant with human immunodeficiency virus type 1 infection and cytomegalovirus encephalitis: case report and review of the literature.
    Rohrer T; Rinaldi D; Bubl R; Engelcke G; Di Gallo A; Rudin C
    Pediatr Infect Dis J; 1999 Apr; 18(4):382-6. PubMed ID: 10223697
    [No Abstract]   [Full Text] [Related]  

  • 66. Cytomegalovirus in an AIDS patient.
    Cunha VS; Dora JM; Fernandes JF; Kelbert S; Sprinz E
    Lancet Infect Dis; 2006 May; 6(5):313. PubMed ID: 16631552
    [No Abstract]   [Full Text] [Related]  

  • 67. Interferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4+ T-cells increase in a patient with AIDS.
    Wen Y; Liu P
    HIV Clin Trials; 2011; 12(2):118-20. PubMed ID: 21498155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy.
    Ortega-Larrocea G; Espinosa E; Reyes-Terán G
    AIDS; 2005 Apr; 19(7):735-8. PubMed ID: 15821403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Zegans M; Marsh B; Walton RC
    Int Ophthalmol Clin; 2000; 40(2):127-35. PubMed ID: 10791261
    [No Abstract]   [Full Text] [Related]  

  • 70. Neovascularization associated with cytomegalovirus retinitis.
    Bogie GJ; Nanda SK
    Retina; 2001; 21(1):85-7. PubMed ID: 11217944
    [No Abstract]   [Full Text] [Related]  

  • 71. Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis.
    Sklar PA; Agyemang AF; Monastra R; Kress DR; Metcalf JA; Robinson MR; Masur H; Polis MA
    AIDS; 2004 Feb; 18(3):567-9. PubMed ID: 15090813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is cytomegalovirus viraemia a useful tool in managing CMV disease?
    Deayton JR
    Sex Transm Infect; 2000 Oct; 76(5):342-4. PubMed ID: 11141848
    [No Abstract]   [Full Text] [Related]  

  • 73. Antiviral chemotherapy.
    Mueller BU
    Curr Opin Pediatr; 1997 Apr; 9(2):178-83. PubMed ID: 9204247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM; Youle MS; Membrey WL; Jones CD
    Lancet; 1997 Aug; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract]   [Full Text] [Related]  

  • 75. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors.
    Walsh JC; Jones CD; Barnes EA; Gazzard BG; Mitchell SM
    AIDS; 1998 Apr; 12(6):613-8. PubMed ID: 9583601
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Opportunistic infections and highly active antiretroviral therapy].
    Gatell JM
    Med Clin (Barc); 2001 Jan; 116(2):56-7. PubMed ID: 11181271
    [No Abstract]   [Full Text] [Related]  

  • 77. Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.
    Jacobson MA; Owen W; Campbell J; Brosgart C; Abrams DI
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S69-73. PubMed ID: 8381032
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytomegalovirus (re)activation plays no role in the ocular vitritis observed after initiation of highly active antiretroviral therapy.
    Boyraz-Ikiz HD; Witmer JP; Frissen PH
    AIDS; 1999 May; 13(7):867. PubMed ID: 10357392
    [No Abstract]   [Full Text] [Related]  

  • 79. Antiretroviral therapy and HIV-related retinal microangiopathy.
    Pivetti-Pezzi P; Accorinti M; Ciapparoni V; Vullo V; Aiuti F
    AIDS; 1997 Dec; 11(15):1890-1. PubMed ID: 9412713
    [No Abstract]   [Full Text] [Related]  

  • 80. Highly active antiretroviral therapy.
    Di Perri G; Bonora S; Vento S; Allegranzi B; Concia E
    Lancet; 1998 Apr; 351(9108):1056; author reply 1058-9. PubMed ID: 9546529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.